Status:
COMPLETED
Inpatient Smokers and LDCT Screening Part 2
Lead Sponsor:
Boston University
Collaborating Sponsors:
American Lung Association
Conditions:
Lung Cancer Screening
Smoking Cessation
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
Lung cancer suffers from large racial and socioeconomic disparities. Yet those at the highest risk of lung cancer death - current smokers, blacks, and individuals with low socioeconomic status (SES) a...
Detailed Description
This study is a randomized controlled trial (RCT) among 128 hospitalized smokers at BMC (64 participants in each of two arms), to assess the effect of inpatient SDM + CHW Navigation (AHRQ LDCT screeni...
Eligibility Criteria
Inclusion
- Hospitalized smoker at BMC
- Meeting LDCT screening eligibility criteria: (age 55-80 years; ≥30-pack years smoking)
- Current smoker (\> 1 cigarette per day)
- Able to speak, read, and understand English
- Able and willing to comply with all study protocols and procedures
- Having a PCP in the BMC network or one of the affiliated health centers
Exclusion
- Inability to tolerate surgical resection of a lung cancer, as defined by home oxygen therapy (an indicator of severe lung cancer or heart disease)
- Active cancer (receiving treatment/new diagnosis) in prior 3 months or advanced stage cancer
- Signs and symptoms of lung cancer or prior diagnosis of lung cancer
- Already had chest CT (LDCT screening or other chest CT) in the past year
- Pregnant
Key Trial Info
Start Date :
February 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03793894
Start Date
February 12 2019
End Date
June 4 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118